Goldman Sachs Drop Coverage of Fulcrum Therapeutics Inc. (NASDAQ: FULC).The analyst comments "We have suspended our investment rating, price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE